The landscape of clinical trials is rapidly transforming. As we move through 2025, smarter technologies and patient-centric ...

Real-world results for blockbuster weight-loss meds like Ozempic, Wegovy and Zepbound aren't as impressive as those promised ...

Poor investigator site selection remains a significant driver of spiraling costs and inefficiencies in clinical development.

At a panel at CTO West Coast, experts from biopharmaceutical companies outlined innovative strategies to shape the future of ...

As stakeholders debate fair market value in clinical trial budgeting, a new task force works to align sponsors, CROs, and ...

New psoriasis drug Zoryve approved. How to use & why Black American participation in clinical trials is vital for health ...

CURE spoke with the principal investigator of a clinical trial evaluating a therapeutic vaccine for patients with advanced ...

GenEditBio has dosed the first subject in an investigator-initiated trial of its in vivo genome editing programme, GEB-101, ...

A phase II clinical trial led by the Alliance for Clinical Trials in Oncology has met its primary endpoint, demonstrating ...

Nerandomilast slowed lung function decline in people with IPF and PPF after a year of treatment, according to data from two ...

VCN-01 has been administered to over 140 patients to date in clinical trials of different cancers, including PDAC (in combination with chemotherapy), head and neck squamous cell carcinoma (with an ...